Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	408-409
Number of pages	2
Journal	New England Journal of Medicine
Volume	393
Issue number	4
DOIs	https://doi.org/10.1056/NEJMc2506672
State	Published - 24 Jul 2025

Access to Document

@article{d6df53a4122a441f8b639463f2e920c2,

title = "Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis",

author = "Andrea Angeletti and Maddalena Maras{\`a} and Paolo Cravedi",

year = "2025",

month = jul,

day = "24",

doi = "10.1056/NEJMc2506672",

language = "English",

volume = "393",

pages = "408--409",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "4",

}

TY - JOUR

T1 - Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

AU - Angeletti, Andrea

AU - Marasà, Maddalena

AU - Cravedi, Paolo

PY - 2025/7/24

Y1 - 2025/7/24

UR - https://www.scopus.com/pages/publications/105012494687

U2 - 10.1056/NEJMc2506672

DO - 10.1056/NEJMc2506672

M3 - Letter

C2 - 40700695

AN - SCOPUS:105012494687

SN - 0028-4793

VL - 393

SP - 408

EP - 409

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 4

ER -